About Viatris
Viatris is a company based in Frankfurt (Germany) founded in 1998 was acquired by Insud Pharma in March 2024.. The company has 32,000 employees as of December 31, 2024. Viatris has completed 3 acquisitions, including Aculys, Famy Life Sciences and Oyster Point Pharmaceuticals. Viatris offers products and services including Generic Medicines and Branded Products.
- Headquarter Frankfurt, Germany
- Employees 32000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Viatris Inc.
-
Annual Revenue
$14.71 B-4.37as on Dec 31, 2024
-
Net Profit
$-634.2 M-1259.41as on Dec 31, 2024
-
EBITDA
$4.57 B-3.44as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Insud Pharma
& 1 more
-
Employee Count
32000
as on Dec 31, 2024
-
Investments & Acquisitions
Aculys
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Viatris
Viatris is a publicly listed company on the NASDAQ with ticker symbol VTRS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Viatris
Viatris offers a comprehensive portfolio of products and services, including Generic Medicines and Branded Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Generic drugs are developed and distributed by Viatris across therapeutic areas to address noncommunicable and infectious diseases.
Branded generics and other medicines are offered by Viatris to enhance access in global markets.
Unlock access to complete
Unlock access to complete
Software Development Team
176 people
Leadership Team
83 people
Senior Team
55 people
Sales and Marketing
54 people
Head Team
44 people
Product Management Team
36 people
Finance and Accounting
28 people
Human Resources and Administration
27 people
Unlock access to complete
Funding Insights of Viatris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Viatris
Viatris has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Insud Pharma and Mylan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finished formulations, APIs, and monoclonal antibodies are developed and manufactured.
|
Founded Year | Domain | Location | |
|
Mylan, part of Viatris, is focused on healthcare solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Viatris
Viatris has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aculys, Famy Life Sciences and Oyster Point Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutic medicines for neuropsychiatric and sleep disorders are developed.
|
2021 | ||||
|
Gene therapies for ophthalmological diseases are developed.
|
2015 | ||||
|
Drug development services are offered for ophthalmology, oncology, and dermatology.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Viatris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Viatris Comparisons
Competitors of Viatris
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Viatris
Frequently Asked Questions about Viatris
When was Viatris founded?
Viatris was founded in 1998.
Where is Viatris located?
Viatris is headquartered in Frankfurt, Germany. It is registered at Frankfurt, Hesse, Germany.
Who is the current CEO of Viatris?
Scott A Smith is the current CEO of Viatris.
How many employees does Viatris have?
As of Dec 31, 2024, the latest employee count at Viatris is 32,000.
What is the annual revenue of Viatris?
Annual revenue of Viatris is $14.71B as on Dec 31, 2024.
What does Viatris do?
Viatris was established in 1998 and is headquartered in Frankfurt, Germany, within the pharmaceuticals sector. Branded drugs are developed and marketed globally by the company, focusing on therapeutic solutions. Operations span research, manufacturing, and distribution across multiple regions. In 2022, annual revenues of 16.26 billion were achieved, alongside a net profit of 2.07 billion. Leadership is provided by CEO Scott A. Smith.
What products or services does Viatris offer?
Viatris offers Generic Medicines and Branded Products.
Is Viatris publicly traded?
Yes, Viatris is publicly traded on NASDAQ under the ticker symbol VTRS.
How many acquisitions has Viatris made?
Viatris has made 3 acquisitions, including Aculys, Famy Life Sciences, and Oyster Point Pharmaceuticals.
Who are Viatris's investors?
Viatris has 2 investors. Key investors include Insud Pharma, and Mylan.
What is Viatris's ticker symbol?
The ticker symbol of Viatris is VTRS on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.